Health, Beauty And Wellness News: Wellements, Le-Vel, Nutrition 21, Delictase
This article was originally published in The Rose Sheet
Executive Summary
Wellements adds infant product; Le-Vel Thrive for Rise Against Hunger; sales post promotions at Nutrition 21; and Delictase reaches colic symptoms.
You may also be interested in...
The MPP And Merck Partner For Molnupiravir In Lower-Income Countries
The Medicines Patent Pool has signed its first agreement to provide access for a COVID-19 medical technology with Merck & Co, to increase access of generic molnupiravir to 150 lower income countries.
Industry Leaders Call For Legal Certainty On Northern Ireland Regulation
The European Commission’s proposals for solving the post-Brexit regulatory problems relating to the Northern Ireland market are welcome but they do not go far enough and risk leaving suppliers in a legal limbo, says the off-patent medicines industry.
NIH Study Keeps Synairgen’s Dream Of An Inhaled COVID-19 Therapy Alive
SNG001 has moved into a Phase III open label trial in which it must prove its non-inferiority against Regeneron's monoclonal antibody cocktail.